Hollencrest Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Hollencrest Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12K	Hold	101	–	–	﹤0.01%	798
2026 Q1	$10.5K	Hold	101	–	–	﹤0.01%	824
2025 Q4	$10.6K	Hold	101	–	–	﹤0.01%	811
2025 Q3	$9.34K	Hold	101	–	–	﹤0.01%	807
2025 Q2	$8.07K	Hold	101	–	–	﹤0.01%	804
2025 Q1	$8.75K	Hold	101	–	–	﹤0.01%	791
2024 Q4	$8.35K	Hold	101	–	–	﹤0.01%	817
2024 Q3	$8.78K	Hold	101	–	–	﹤0.01%	774
2024 Q2	$8.3K	Hold	101	–	–	﹤0.01%	767
2024 Q1	$8.1K	Hold	101	–	–	﹤0.01%	739
2023 Q4	$7.69K	Hold	101	–	–	﹤0.01%	754
2023 Q3	$7.31K	Hold	101	–	–	﹤0.01%	768
2023 Q2	$7.64K	Hold	101	–	–	﹤0.01%	789
2023 Q1	$7.68K	Hold	101	–	–	﹤0.01%	786
2022 Q4	$7.94K	Buy	+101	New	+$7.76K	﹤0.01%	753
2016 Q2	–	Sell	-22,141	Closed	-$1.33M	–	445
2016 Q1	$1.33M	Sell	22,141 -653	-3%	-$39.9K	0.23%	84
2015 Q4	$1.59M	Buy	+22,794	New	+$1.62M	0.28%	80

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Hollencrest Capital Management's PJP Position: Q2 2026 in Review

Hollencrest Capital Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 101 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

Hollencrest Capital Management first reported a position in PJP in Q4 2015 and has held it in 17 quarters since. The position peaked at $1.59M in Q4 2015. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Hollencrest Capital Management held 101 shares of Invesco Pharmaceuticals ETF worth $12K as of Q2 2026.
Hollencrest Capital Management left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #798 holding.
Hollencrest Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and has held it in 17 quarters since.
Hollencrest Capital Management's Invesco Pharmaceuticals ETF position peaked at $1.59M in Q4 2015.
116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.